A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Netazepide (Primary)
- Indications Gastric atrophy; Gastric cancer
- Focus Therapeutic Use
- Sponsors Trio Medicines
- 17 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 17 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
- 10 Jun 2017 Biomarkers information updated